Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 08 Mar 2023
While some say this strategy's failure rate is "too high," it's one step closer to the "white grail" of a shorter 24-week formula.
Read Full NewsListener feedback, more long-term data on the TAVR/SAVR question, population prevalence of valvular heart disease in the US, and a CMS proposal to expand TAVR coverage are the topics John Mandrola, MD, discusses in this week’s podcast.
False claims about poultry vaccination continue to circulate despite evidence supporting its role in protecting livestock and limiting the spread of avian influenza.
Severe esophageal symptoms that do not respond to standard treatment may warrant endoscopic evaluation and targeted diagnostic testing.
10-hour time-restricted eating promotes greater weight loss and improved body composition in adults with obesity and without diabetes than standard dietary counseling alone.
Panelists at HLTH Europe 2026 warned that clinicians and patients are increasingly deferring to algorithmic outputs over independent judgment.
In patients with systemic sclerosis, specific gastrointestinal manifestations are linked to distinct cardiac complications, a recent study shows.
1.
It Is Cancer in Kate Middleton.
2.
Treatment of Oligometastatic EGFR-Mutant Lung Cancer
3.
Study supports routine brain MRI screening in asymptomatic late-stage breast cancer patients
4.
In myelofibrosis, combinations of rufolitinib reduce spleen volume.
5.
Researchers find distinct cell receptors with the potential for new treatments.
1.
First-Line Immuno-Hematology Examinations: Essential Diagnostic Tools for Patient Care
2.
Unlocking the Potential of Onivyde: A New Hope for Cancer Treatment
3.
Understanding Bone Metastases: How Long Can Someone Live When Cancer Spreads To The Bones?
4.
Unleashing the Oncolytic Arsenal: Talimogene Laherparepvec Monotherapy – A Targeted Cancer Immunotherapy Treatment
5.
How Cancer Cells Evade Immune Destruction and the Fight Back
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
International Lung Cancer Congress®
1.
A Conclusive Discussion on CROWN Trial and the Dawn of a New Era in Frontline Management of ALK+ NSCLC
2.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part II
3.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part V
4.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part V
5.
Key Takeaways from The CROWN Trial For ALK + NSCLC Patients with CNS Diseases
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge